Lipidomics in drug discovery

被引:18
|
作者
Vihervaara, Terhi
Suoniemi, Matti
Laaksonen, Reijo
机构
[1] Zora Biosciences Oy, Biologinkuja 1
关键词
MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; MOLECULAR LIPIDOMICS; TRIPLE QUADRUPOLE; PROSTATE-CANCER; HUMAN PLASMA; SPHINGOLIPIDS; LIPIDS; ACID; METABOLISM;
D O I
10.1016/j.drudis.2013.09.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipidomics is a rapidly growing technology that can be used in biomedical research to study disease mechanisms, identify novel disease biomarkers and drug efficacy biomarkers, and reveal off-target effects. Lipidomics can also be used to elucidate the mechanism of action of different drug compounds or as readouts in Mendelian randomization approaches. Furthermore, lipidomics can be utilized to identify deviations in metabolic and/or signaling pathways in different stages of disease. Therefore, as we discuss here, this emerging technology also has a substantial potential in various drug discovery programs.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 50 条
  • [1] Lipidomics In Disease And Drug Discovery
    Dennis, Edward A.
    FASEB JOURNAL, 2016, 30
  • [2] Lipidomics analysis in drug discovery and development
    Kostidis, Sarantos
    Sanchez-Lopez, Elena
    Giera, Martin
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2023, 72
  • [3] Membrane lipidomics for the discovery of new antiparasitic drug targets
    Marechal, Eric
    Riou, Mickael
    Kerboeuf, Dominique
    Beugnet, Frederic
    Chaminade, Pierre
    Loiseau, Philippe M.
    TRENDS IN PARASITOLOGY, 2011, 27 (11) : 496 - 504
  • [4] The emerging role of plasma lipidomics in cardiovascular drug discovery
    Puri, Rishi
    MyNgan Duong
    Uno, Kiyoko
    Kataoka, Yu
    Nicholls, Stephen J.
    EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (01) : 63 - 72
  • [5] Metabolomics and lipidomics strategies in modern drug discovery and development
    Astarita, Giuseppe
    Kelly, Rachel S.
    Lasky-Su, Jessica
    DRUG DISCOVERY TODAY, 2023, 28 (10)
  • [6] How lipidomics provides new insight into drug discovery
    Lamaziere, Antonin
    Wolf, Claude
    Quinn, Peter J.
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (07) : 819 - 836
  • [7] Lipidomics-driven drug discovery and delivery strategies in glioblastoma
    Weng, Xiaohui
    Gonzalez, Michael
    Angelia, Jeannes
    Piroozmand, Somayeh
    Jamehdor, Saleh
    Behrooz, Amir Barzegar
    Latifi-Navid, Hamid
    Ahmadi, Mazaher
    Pecic, Stevan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (03):
  • [8] The growing landscape of metabolomics and lipidomics: applications to medicinal chemistry and drug discovery
    Palacios, Gustavo
    Bowling, John J.
    Abdolvahabi, Alireza
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (06) : 495 - 498
  • [9] Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challenges
    Abrahams, Timothy
    Nicholls, Stephen J.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (03) : 281 - 290
  • [10] Advances in Lipidomics for Cancer Biomarkers Discovery
    Perrotti, Francesca
    Rosa, Consuelo
    Cicalini, Ilaria
    Sacchetta, Paolo
    Del Boccio, Piero
    Genovesi, Domenico
    Pieragostino, Damiana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (12)